PINS - Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Raymond James raised Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) price target from $12 to $15. Raymond James analyst Rahul Sarugaser upgraded the stock from Outperform to Strong Buy. Fusion Pharmaceuticals shares jumped 16.7% to close at $7.97 on Tuesday. See how other analysts view this stock.
- BTIG boosted the price target for Organogenesis Holdings Inc. (NASDAQ: ORGO) from $4 to $6. BTIG analyst Ryan Zimmerman maintained a Buy rating. Organogenesis shares gained 0.3% to close at $3.97 on Tuesday. See how other analysts view this stock.
- Canaccord Genuity boosted the price target for Aspen Aerogels, Inc. (NYSE: ASPN) from $13 to $17. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. Aspen ...